V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216030 | 20155753 | 1.84 | 76 | Palliative (P) | 2021-03-11 | 2021-03-25 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100915010 |
| 20216035 | 20155754 | 1.86 | 65.4 | Palliative (P) | 2020-01-24 | 2020-03-20 | EOX | Y | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101025635 |
| 20216037 | 20155755 | 1.7 | 67.7 | Palliative (P) | 2021-06-07 | 2021-07-05 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101352165 |
| 20216041 | 20155756 | 1.62 | 62.8 | null | 2019-04-24 | 2019-05-01 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100510898 |
| 20216043 | 20155757 | 1.63 | 82.65 | null | 2018-08-18 | 2018-08-20 | EOX | 02 | null | EOX | 100160513 |
| 20216045 | 20155758 | 1.61 | 61 | Neo-adjuvant (N) | 2020-06-13 | 2020-06-15 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 101433036 |
| 20216049 | 20155759 | 1.55 | 67.6 | Palliative (P) | 2020-12-15 | 2020-12-15 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101184128 |
| 20216050 | 20155760 | 1.78 | 87.8 | null | 2018-11-28 | 2019-01-04 | Oxaliplatin + Raltitrexed | N | Y | OXALIPLATIN + RALTITREXED | 100652963 |
| 20216051 | 20155761 | 1.57 | 98.1 | null | 2018-06-13 | 2018-07-02 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101195042 |
| 20216052 | 20155762 | 1.57 | 87.8 | Curative (C) | 2020-08-26 | 2020-12-14 | EOX | 2 | N | EOX | 101521725 |
| 20216053 | 20155763 | 1.92 | 73.8 | Curative (C) | 2019-02-08 | 2019-03-26 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100299160 |
| 20216056 | 20155764 | 1.83 | 88.2 | Curative (C) | 2018-06-30 | 2018-10-18 | Sorafenib | 02 | N | SORAFENIB | 101520279 |
| 20216057 | 20155765 | 1.72 | 57.8 | Palliative (P) | 2019-05-26 | 2020-02-28 | Sorafenib | 02 | N | SORAFENIB | 101029458 |
| 20216059 | 20155766 | 1.87 | 64.7 | Palliative (P) | 2021-05-17 | 2021-10-10 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100967324 |
| 20216067 | 20155767 | 1.57 | 79.4 | Palliative (P) | 2018-04-28 | 2018-06-23 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100741522 |
| 20216070 | 20155768 | 1.63 | 91.5 | Palliative (P) | 2019-12-10 | 2020-02-11 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100913970 |
| 20216074 | 20155769 | 1.61 | 103 | Palliative (P) | 2016-03-17 | 2017-12-19 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101290405 |
| 20216075 | 20155770 | 0 | 54.3 | Adjuvant (A) | 2019-05-03 | 2019-05-03 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101094289 |
| 20216079 | 20155771 | 1.56 | 71.2 | Curative (C) | 2017-11-04 | 2018-03-25 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101582057 |
| 20216082 | 20155772 | 1.73 | 96.2 | Disease modification (D) | 2018-06-30 | 2018-07-01 | Trial Unspecified | N | Y | TRIAL | 100772709 |
| 20216083 | 20155773 | 1.82 | 47 | null | 2020-04-11 | 2020-04-29 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100911880 |
| 20216084 | 20155774 | 1.83 | 76.2 | Palliative (P) | 2016-05-05 | 2016-05-05 | EOX | N | N | TRIAL | 100742023 |
| 20216094 | 20155775 | 1.63 | 116.6 | null | 2020-11-26 | 2020-12-11 | Capecitabine 35days + RT | N | null | CAPECITABINE + RT | 101138290 |
| 20216097 | 20155776 | 1.7 | 82 | Palliative (P) | 2020-10-05 | 2020-10-19 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100647320 |
| 20216107 | 20155777 | 1.84 | 48.6 | Palliative (P) | 2016-08-03 | 2016-09-04 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100527088 |
| 20216108 | 20155778 | 1.83 | 75.85 | Palliative (P) | 2018-03-01 | 2018-04-04 | EOX | 02 | Y | EOX | 101771280 |
| 20216109 | 20155779 | 1.7 | 88.4 | Palliative (P) | 2018-07-27 | 2018-07-27 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101378428 |
| 20216110 | 20155780 | 1.55 | 88.8 | null | 2019-12-22 | 2020-01-30 | EOX | 02 | null | CAPECITABINE + RT | 100655310 |
| 20216114 | 20155781 | 1.7 | 103.9 | Palliative (P) | 2021-06-08 | 2021-08-02 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101013378 |
| 20216115 | 20155782 | 1.66 | 83.1 | Palliative (P) | 2017-12-15 | 2018-01-18 | EOX | 02 | N | SORAFENIB | 100063477 |
| 20216116 | 20155783 | 1.66 | 56.8 | 03 | 2016-06-21 | 2016-07-20 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101181434 |
| 20216118 | 20155784 | 1.76 | 77 | Adjuvant (A) | 2016-12-22 | 2017-01-07 | Trial Unspecified | N | N | EOX | 100744695 |
| 20216120 | 20155785 | 1.54 | 56.1 | Disease modification (D) | 2016-09-05 | 2016-09-19 | EOX | 02 | N | TRIAL | 101160883 |
| 20216123 | 20155786 | 1.59 | 60 | null | 2017-02-04 | 2017-02-23 | EOX | 02 | null | SORAFENIB | 100591984 |
| 20216125 | 20155787 | 1.67 | 77.1 | Palliative (P) | 2020-03-08 | 2020-07-13 | Trial Unspecified | Y | N | TRIAL | 101275877 |
| 20216130 | 20155788 | 1.9 | 56 | Palliative (P) | 2018-02-12 | 2018-02-20 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 101029398 |
| 20216132 | 20155789 | 1.72 | 41.6 | 03 | 2018-06-28 | 2018-11-13 | IRINOTECAN + MDG + PANITUMUMAB | 99 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101680584 |
| 20216134 | 20155790 | 1.76 | 76.8 | Adjuvant (A) | 2019-10-17 | 2019-10-17 | EOX | 1 | null | OXALIPLATIN + RALTITREXED | 101682919 |
| 20216136 | 20155791 | 1.82 | 73.4 | Adjuvant (A) | 2020-10-25 | 2020-11-01 | IRINOTECAN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101420815 |
| 20216140 | 20155792 | 1.74 | 63.5 | Neo-adjuvant (N) | 2016-07-23 | 2016-11-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101844809 |
| 20216142 | 20155793 | 1.71 | 81.9 | Curative (C) | 2018-11-16 | 2018-11-17 | EOX | N | Y | OXALIPLATIN + RALTITREXED | 100069535 |
| 20216147 | 20155794 | 1.64 | 59 | null | 2017-04-17 | 2017-04-25 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101612934 |
| 20216148 | 20155795 | 1.53 | 53.7 | Adjuvant (A) | 2018-06-16 | 2018-06-17 | Capecitabine 35days + RT | N | N | OXALIPLATIN + RALTITREXED | 100242354 |
| 20216153 | 20155796 | 1.53 | 55.2 | Palliative (P) | 2019-08-02 | 2019-08-02 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101561537 |
| 20216155 | 20155797 | 1.41 | 69.3 | null | 2017-05-01 | 2017-05-01 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100543350 |
| 20216156 | 20155798 | 1.82 | 73.4 | 03 | 2017-08-21 | 2017-09-05 | CAPECITABINE + RT | 02 | Y | CAPECITABINE + RT | 100774509 |
| 20216158 | 20155799 | 1.66 | 97.4 | Palliative (P) | 2017-05-08 | 2017-05-11 | Cetuximab + FOLFIRI cycle 2 onwards | 01 | Y | CETUXIMAB + IRINOTECAN + MDG | 100215170 |
| 20216160 | 20155800 | 0 | 48 | Palliative (P) | 2018-04-06 | 2019-07-30 | EOX | 02 | Y | EOX | 100429130 |
| 20216161 | 20155801 | 178.5 | 77.4 | Palliative (P) | 2017-08-03 | 2017-08-11 | Trial Unspecified | 02 | N | TRIAL | 101415198 |
| 20216162 | 20155802 | 1.93 | 58.8 | Adjuvant (A) | 2017-02-21 | 2017-02-25 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101473244 |